Bg pattern

AGRELAN 75 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AGRELAN 75 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

AGRELAN 75 mg film-coated tablets EFG

Clopidogrel

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What Agrelan is and what it is used for.
  2. Before you take Agrelan.
  3. How to take Agrelan.
  4. Possible side effects.
  5. Storing Agrelan.
  6. Further information.

1. What Agrelan is and what it is used for

AGRELAN belongs to a group of medicines called antiplatelet agents. Platelets are very small structures in the blood that are smaller than red or white blood cells and clump together when the blood clots. Antiplatelet agents prevent this clumping, reducing the risk of blood clots (a process called thrombosis) forming.

AGRELAN is given to prevent the formation of blood clots (thrombi) in blood vessels (arteries) that have become hardened, a process known as atherothrombosis, which can cause atherothrombotic events (such as stroke, myocardial infarction, or death).

You have been prescribed AGRELAN to help prevent the formation of blood clots and reduce the risk of these serious events because:

  • You have a process that causes hardening of the arteries (also called atherosclerosis), or
  • You have previously had a myocardial infarction, a stroke, or suffer from a disease called peripheral arterial disease, or
  • You have had a severe type of chest pain, known as "unstable angina" or "myocardial infarction". For the treatment of this disease, your doctor may have prescribed AGRELAN in combination with acetylsalicylic acid, a substance present in many medications used to relieve pain and reduce fever, as well as to prevent blood clots.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before you take Agrelan

Do not take Agrelan

  • If you are allergic (hypersensitive) to clopidogrel or any of the other ingredients of Agrelan;
  • If you have an active bleeding, such as a stomach ulcer or bleeding in the brain;
  • If you have a severe liver disease.

If you think any of these apply to you, or if you are unsure, consult your doctor before taking Agrelan.

Be cautious when taking Agrelan

Before starting treatment with Agrelan, inform your doctor if you are in any of the following situations:

  • If you are at risk of bleeding (bleeding) because:
    • You have a disease that involves a risk of internal bleeding (such as a stomach ulcer).
    • You have a blood disorder that predisposes you to internal bleeding (bleeding in tissues, organs, or joints of the body).
    • You have recently had a serious injury.
    • You have recently undergone surgery (including dental surgery).
    • You are scheduled to undergo surgery (including dental surgery) within the next seven days.
  • If you have had a blood clot in an artery of the brain (ischemic stroke) in the last 7 days.
  • If you are taking other medications (see "Using other medications").
  • If you have liver or kidney disease.

During treatment with Agrelan:

  • Tell your doctor if you are scheduled to undergo surgery (including dental surgery).
  • Tell your doctor immediately if you develop a disorder that includes fever and bruising (bruises) under the skin that can appear as red spots, with or without unexplained extreme fatigue, confusion, yellowing of the skin or eyes (jaundice) (see section 4 "Possible side effects").
  • If you cut or injure yourself, the bleeding may take longer than usual to stop. This is related to the way the medication works, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cutting yourself while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see "Be cautious when taking Agrelan").
  • Your doctor may ask you to have blood tests.
  • Tell your doctor or pharmacist if you notice any side effects not mentioned in this leaflet or if you notice that any side effect worsens.

Agrelan should not be given to children or adolescents.

Taking Agrelan with other medications

Some medications may affect the use of Agrelan or vice versa.

Tell your doctor or pharmacist if you are taking or have recently taken other medications, including those obtained without a prescription.

Concomitant administration of Agrelan with oral anticoagulants (medications used to decrease blood clotting) is not recommended.

You must explicitly inform your doctor if you are taking:

  • Ticlopidine, another antiplatelet agent; non-steroidal anti-inflammatory drugs, medications commonly used to treat pain and/or inflammation of muscles or joints, or if you are taking heparin, or any other medication used to decrease blood clotting, or if you are taking a proton pump inhibitor (e.g., omeprazole) for stomach discomfort.
  • Antiretrovirals (medications for treating HIV infection).

If you have had severe chest pain (unstable angina or myocardial infarction), you may have been prescribed Agrelan in combination with acetylsalicylic acid, a substance present in many medications used to relieve pain and reduce fever. An occasional dose of acetylsalicylic acid (not exceeding 1,000 mg in 24 hours) should not cause any problems, but prolonged use in other circumstances should be discussed with your doctor.

Taking Agrelan with food and drinks

Agrelan can be taken with or without food.

Pregnancy and breastfeeding

It is preferable not to use this medication during pregnancy and breastfeeding.

If you are pregnant or think you may be pregnant, you must inform your doctor or pharmacist before taking Agrelan. If you become pregnant while taking Agrelan, consult your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.

If you are taking Agrelan, consult your doctor about breastfeeding.

Consult your doctor or pharmacist before using any medication.

Driving and using machines

It is unlikely that Agrelan will affect your ability to drive or operate machinery.

Important information about some of the ingredients of Agrelan

Agrelan contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Agrelan

Follow the instructions for taking Agrelan exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.

If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe 300 mg of Agrelan (4 tablets of 75 mg) to be taken once at the start of treatment. Afterward, the usual dose is one 75 mg tablet of Agrelan per day, taken orally, with or without food, and at the same time each day.

You should take Agrelan for as long as your doctor continues to prescribe it.

If you take more Agrelan than you should

Contact your doctor or go to the nearest hospital emergency department or call the Toxicology Information Service, phone 91 5620420, indicating the medication and the amount ingested, as there is an increased risk of bleeding.

If you forget to take a dose of Agrelan, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.

If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for the missed dose.

If you stop taking Agrelan

Do not stop your treatment. Contact your doctor or pharmacist before stopping this medication.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Agrelan can have side effects, although not everyone gets them.

Contact your doctor immediately if you experience:

  • Fever, signs of infection, or severe fatigue. These symptoms may be due to a rare decrease in some blood cells.
  • Signs of liver problems, such as yellowing of the skin and/or eyes (jaundice), associated or not with bleeding that appears under the skin as red spots and/or confusion (see "Be cautious when taking Agrelan").
  • Swelling of the mouth or skin disorders such as rashes and itching, blisters on the skin.

These can be signs of an allergic reaction.

The most common side effect reported with Agrelan(affecting between 1 and 10 patients in 100) is bleeding. Bleeding can occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A reduced number of cases of bleeding in the blood vessels of the eyes, intracranial bleeding, pulmonary or joint bleeding have also been reported.

If you experience prolonged bleeding while taking Agrelan

If you cut or injure yourself, it is possible that the bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medication, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cutting yourself while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see "Be cautious when taking Agrelan").

Other side effects reported with Agrelan are:

Common side effects (affecting between 1 and 10 patients in 100): Diarrhea, abdominal pain, indigestion, or heartburn.

Uncommon side effects (affecting between 1 and 10 patients in 1,000): Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling sensation, and numbness.

Rare side effects (affecting between 1 and 10 patients in 10,000): Vertigo.

Very rare side effects (affecting less than 1 patient in 10,000): Jaundice, severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions; swelling of the mouth; blisters on the skin, skin allergy; inflammation of the mouth mucosa (stomatitis); decreased blood pressure; confusion; hallucinations; joint pain; muscle pain; altered taste; eosinophilic pneumonia; acquired hemophilia A.

Frequency unknown: hypersensitivity reactions.

In addition, your doctor may observe changes in the results of your blood or urine tests.

Reporting side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storing Agrelan

Keep out of the reach and sight of children.

Do not use Agrelan after the expiration date stated on the carton and blister.

This medication does not require special storage conditions.

Do not use Agrelan if you notice any visible signs of deterioration.

Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications and packaging you no longer need. This will help protect the environment.

6. Further information

Composition of Agrelan

The active ingredient is clopidogrel. Each tablet contains 75 mg of clopidogrel (as besylate).

The other ingredients are: microcrystalline cellulose, mannitol (E421), hydroxypropylcellulose, crospovidone, citric acid, polyethylene glycol 6000, stearic acid, talc, and as coating components: Hypromellose (E464), red iron oxide (E172), lactose monohydrate, triacetin (E1518), and titanium dioxide (E171).

Appearance of the product and pack contents

The Agrelan 75 mg tablets are round, biconvex, pink, and film-coated. They are available in cardboard boxes of 28 tablets in PA/ALL/PVC-Aluminum (Aluminum-Aluminum) or PVC/PE/PVDC aluminum blisters.

Marketing authorization holder and manufacturer

Marketing authorization holder:

ESPECIALIDADES FARMACEUTICAS CENTRUM S.A.

C/ Sagitario, 14

03006 Alicante

Spain

Manufacturer:

Pharmathen, S.A.

6, Dervanakion street, Pallini 15351

Attiki

Greece

or

HARMATHEN INTERNATIONAL S.A.

Sapes Industrial Park, Block 5

Rodopi

Greece

This leaflet was last revised in July 2019

Online doctors for AGRELAN 75 mg FILM-COATED TABLETS

Discuss questions about AGRELAN 75 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for AGRELAN 75 mg FILM-COATED TABLETS?
AGRELAN 75 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in AGRELAN 75 mg FILM-COATED TABLETS?
The active ingredient in AGRELAN 75 mg FILM-COATED TABLETS is clopidogrel. This information helps identify medicines with the same composition but different brand names.
How much does AGRELAN 75 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for AGRELAN 75 mg FILM-COATED TABLETS is around 16.81 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures AGRELAN 75 mg FILM-COATED TABLETS?
AGRELAN 75 mg FILM-COATED TABLETS is manufactured by Especialidades Farmaceuticas Centrum S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of AGRELAN 75 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AGRELAN 75 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to AGRELAN 75 mg FILM-COATED TABLETS?
Other medicines with the same active substance (clopidogrel) include CLOPIDOGREL ALMUS 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALTER 75 mg FILM-COATED TABLETS, CLOPIDOGREL AUROVITAS 75 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media